These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 12815543)
1. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea. Anand B; Nashed Y; Mitra A Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543 [TBL] [Abstract][Full Text] [Related]
2. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model. Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053 [TBL] [Abstract][Full Text] [Related]
3. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium. Anand BS; Katragadda S; Nashed YE; Mitra AK Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962 [TBL] [Abstract][Full Text] [Related]
4. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter. Han HK; Oh DM; Amidon GL Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889 [TBL] [Abstract][Full Text] [Related]
5. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections. Katragadda S; Gunda S; Hariharan S; Mitra AK Int J Pharm; 2008 Jul; 359(1-2):15-24. PubMed ID: 18472234 [TBL] [Abstract][Full Text] [Related]
6. Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations. Majumdar S; Nashed YE; Patel K; Jain R; Itahashi M; Neumann DM; Hill JM; Mitra AK J Ocul Pharmacol Ther; 2005 Dec; 21(6):463-74. PubMed ID: 16386088 [TBL] [Abstract][Full Text] [Related]
7. Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity. Vadlapudi AD; Vadlapatla RK; Earla R; Sirimulla S; Bailey JB; Pal D; Mitra AK Pharm Res; 2013 Aug; 30(8):2063-76. PubMed ID: 23657675 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea. Anand BS; Mitra AK Pharm Res; 2002 Aug; 19(8):1194-202. PubMed ID: 12240946 [TBL] [Abstract][Full Text] [Related]
9. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2. Anand BS; Patel J; Mitra AK J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism. Anand BS; Katragadda S; Mitra AK J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381 [TBL] [Abstract][Full Text] [Related]
11. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line. Tak RV; Pal D; Gao H; Dey S; Mitra AK J Pharm Sci; 2001 Oct; 90(10):1505-15. PubMed ID: 11745709 [TBL] [Abstract][Full Text] [Related]
12. Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir. Jwala J; Boddu SH; Shah S; Sirimulla S; Pal D; Mitra AK J Ocul Pharmacol Ther; 2011 Apr; 27(2):163-72. PubMed ID: 21500985 [TBL] [Abstract][Full Text] [Related]
13. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits. Anand BS; Katragadda S; Gunda S; Mitra AK Mol Pharm; 2006; 3(4):431-40. PubMed ID: 16889437 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous modulation of transport and metabolism of acyclovir prodrugs across rabbit cornea: An approach involving enzyme inhibitors. Katragadda S; Talluri RS; Mitra AK Int J Pharm; 2006 Aug; 320(1-2):104-13. PubMed ID: 16720085 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design. Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738 [TBL] [Abstract][Full Text] [Related]
16. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis]. Shimomura Y Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713 [TBL] [Abstract][Full Text] [Related]
17. Identification of a Na+-dependent cationic and neutral amino acid transporter, B(0,+), in human and rabbit cornea. Jain-Vakkalagadda B; Pal D; Gunda S; Nashed Y; Ganapathy V; Mitra AK Mol Pharm; 2004; 1(5):338-46. PubMed ID: 16026003 [TBL] [Abstract][Full Text] [Related]
18. Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: targeting the oligopeptide transporter on rabbit retina. Kansara V; Hao Y; Mitra AK J Ocul Pharmacol Ther; 2007 Aug; 23(4):321-34. PubMed ID: 17803430 [TBL] [Abstract][Full Text] [Related]
19. Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: An evaluation using ocular microdialysis and LC-MS. Dias C; Nashed Y; Atluri H; Mitra A Curr Eye Res; 2002 Oct; 25(4):243-52. PubMed ID: 12658558 [TBL] [Abstract][Full Text] [Related]